Literature DB >> 17928209

Effects of a low-calorie diet associated with weight loss on lipoprotein-associated phospholipase A2 (Lp-PLA2) activity in healthy obese women.

T Tzotzas1, T D Filippatos, A Triantos, E Bruckert, A D Tselepis, D N Kiortsis.   

Abstract

INTRODUCTION: Platelet-activating factor acetylhydrolase (PAF-AH or Lp-PLA(2)) is a Ca(2+)-independent phospholipase A(2) primarily associated in plasma with low density lipoproteins (LDL), especially with small dense LDL (sdLDL) particles. Increased plasma Lp-PLA(2) levels have been associated with increased cardiovascular risk in large clinical trials. AIM: To assess the effects of weight loss on Lp-PLA(2) activity and to examine the association of Lp-PLA(2) activity changes with the alterations of sdLDL, the primary carrier of Lp-PLA(2) in plasma.
METHODS: Twenty-eight obese, non-diabetic women participated in a weight reduction program. Anthropometric parameters were assessed and parameters of glucose metabolism, lipid profile, Lp-PLA(2) activity, and LDL phenotype (using a 3% polyacrylamide gel-tube electrophoresis method), were determined at baseline and after 4months of weight loss.
RESULTS: A 10% diet-induced weight loss resulted in significant improvement in most parameters of lipid and glucose metabolism. Moreover, Lp-PLA(2) activity was significantly reduced (-10.2%, p<0.01). Mean LDL particle diameter did not change after the weight loss program. The cholesterol levels of very low-density lipoprotein (VLDL) and large-buoyant LDL particles were significantly reduced, but neither the cholesterol levels of sdLDL particles nor the % proportion of the sdLDL-cholesterol over the total LDL-cholesterol were changed after the intervention program. Interestingly, the changes in Lp-PLA(2) activity were correlated with the changes of VLDL-cholesterol (r=0.39, p<0.05), but not with the changes of anthropometric or other lipid variables.
CONCLUSIONS: A low-calorie diet associated with weight loss in obese women resulted in the significant reduction of the plasma levels of Lp-PLA(2), the potentially new predictor for incident atherosclerotic disease.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17928209     DOI: 10.1016/j.numecd.2007.04.004

Source DB:  PubMed          Journal:  Nutr Metab Cardiovasc Dis        ISSN: 0939-4753            Impact factor:   4.222


  16 in total

Review 1.  The Mediterranean diet: effects on proteins that mediate fatty acid metabolism in the colon.

Authors:  Zora Djuric
Journal:  Nutr Rev       Date:  2011-12       Impact factor: 7.110

2.  Small high-density lipoprotein (HDL) subclasses are increased with decreased activity of HDL-associated phospholipase A₂ in subjects with prediabetes.

Authors:  Theodosios D Filippatos; Evangelos C Rizos; Vasilios Tsimihodimos; Irene F Gazi; Alexandros D Tselepis; Moses S Elisaf
Journal:  Lipids       Date:  2013-04-02       Impact factor: 1.880

Review 3.  Does combination therapy with statins and fibrates prevent cardiovascular disease in diabetic patients with atherogenic mixed dyslipidemia?

Authors:  Aris P Agouridis; Christos V Rizos; Moses S Elisaf; Theodosios D Filippatos
Journal:  Rev Diabet Stud       Date:  2013-08-10

4.  Replacing with whole grains and legumes reduces Lp-PLA2 activities in plasma and PBMCs in patients with prediabetes or T2D.

Authors:  Minjoo Kim; Se Ri Jeung; Tae-Sook Jeong; Sang-Hyun Lee; Jong Ho Lee
Journal:  J Lipid Res       Date:  2014-06-05       Impact factor: 5.922

Review 5.  Effects of dietary factors on lipoprotein-associated phospholipase A(2) (Lp-PLA (2)).

Authors:  Cheuk-Kit Wong; Harvey D White
Journal:  Curr Atheroscler Rep       Date:  2011-12       Impact factor: 5.113

6.  PAF signaling plays a role in obesity-induced adipose tissue remodeling.

Authors:  Kátia A Costa; Débora R Lacerda; Ana L M Silveira; Laís B Martins; Marina C Oliveira; Barbara M Rezende; Zélia Menezes-Garcia; Fernanda L B Mügge; Aristóbolo M Silva; Mauro M Teixeira; Christine Rouault; Vanessa Pinho; Geneviève Marcelin; Karine Clément; Adaliene V M Ferreira
Journal:  Int J Obes (Lond)       Date:  2021-09-07       Impact factor: 5.095

7.  Lipoprotein-associated phospholipase A2 activity in obese adolescents with and without type 2 diabetes.

Authors:  Julia Seyfarth; Thomas Reinehr; Annika Hoyer; Christina Reinauer; Christina Bächle; Beate Karges; Ertan Mayatepek; Michael Roden; Sabine E Hofer; Susanna Wiegand; Joachim Woelfle; Wieland Kiess; Joachim Rosenbauer; Reinhard W Holl; Thomas Meissner
Journal:  J Inherit Metab Dis       Date:  2017-10-13       Impact factor: 4.982

8.  Dietary, lifestyle, and clinical predictors of lipoprotein-associated phospholipase A2 activity in individuals without coronary artery disease.

Authors:  Ida J Hatoum; Jeanenne J Nelson; Nancy R Cook; Frank B Hu; Eric B Rimm
Journal:  Am J Clin Nutr       Date:  2010-01-27       Impact factor: 7.045

Review 9.  Antioxidant and inflammatory aspects of lipoprotein-associated phospholipase A₂ (Lp-PLA₂): a review.

Authors:  Isis T Silva; Ana P Q Mello; Nágila R T Damasceno
Journal:  Lipids Health Dis       Date:  2011-09-28       Impact factor: 3.876

10.  Lipoprotein-associated phospholipase A2 (Lp-PLA2) activity, platelet-activating factor acetylhydrolase (PAF-AH) in leukocytes and body composition in healthy adults.

Authors:  Paraskevi Detopoulou; Tzortzis Nomikos; Elizabeth Fragopoulou; Demosthenis B Panagiotakos; Christos Pitsavos; Christodoulos Stefanadis; Smaragdi Antonopoulou
Journal:  Lipids Health Dis       Date:  2009-06-05       Impact factor: 3.876

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.